M. Falqués

Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan

G Zanchin, G Géraud, Nina De Klippel et al. · Cephalalgia · 2008 · 219 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial

Bianca Maria Piraccini, Ulrike Blume‐Peytavi, F. Scarci et al. · Journal of the European Academy of Dermatology and Venereology · 2021 · 157 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase <scp>III</scp> clinical trials (re <scp>SURFACE</scp> 1 and re <scp>SURFACE</scp> 2) through 148 weeks

Kristian Reich, Richard B. Warren, Lars Iversen et al. · British Journal of Dermatology · 2019 · 143 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Randomised clinical trials: linaclotide phase 3 studies in <scp>IBS</scp> ‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints

Eamonn M.M. Quigley, Jan Tack, William D. Chey et al. · Alimentary Pharmacology & Therapeutics · 2012 · 125 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)*

Diamant Thaçi, Stefano Piaserico, Richard B. Warren et al. · British Journal of Dermatology · 2021 · 96 citations · Full text

Medicine, Dermatology, Pharmacotherapy +16